Copyright Reports & Markets. All rights reserved.

Global Zonisamide Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Zonisamide Market Overview

      • 1.1 Product Overview and Scope of Zonisamide
      • 1.2 Zonisamide Segment by Type
        • 1.2.1 Global Zonisamide Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 25mg
        • 1.2.3 50mg
        • 1.2.4 100mg
      • 1.3 Zonisamide Segment by Application
        • 1.3.1 Zonisamide Consumption Comparison by Application (2014-2025)
        • 1.3.2 Adult
        • 1.3.3 Pediatric
        • 1.3.4 Geriatric
      • 1.4 Global Zonisamide Market by Region
        • 1.4.1 Global Zonisamide Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Zonisamide Market Size
        • 1.5.1 Global Zonisamide Revenue (2014-2025)
        • 1.5.2 Global Zonisamide Production (2014-2025)

      2 Global Zonisamide Market Competition by Manufacturers

      • 2.1 Global Zonisamide Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Zonisamide Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Zonisamide Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Zonisamide Production Sites, Area Served, Product Types
      • 2.5 Zonisamide Market Competitive Situation and Trends
        • 2.5.1 Zonisamide Market Concentration Rate
        • 2.5.2 Zonisamide Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Zonisamide Production Market Share by Regions

      • 3.1 Global Zonisamide Production Market Share by Regions
      • 3.2 Global Zonisamide Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Zonisamide Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Zonisamide Production
        • 3.4.1 North America Zonisamide Production Growth Rate (2014-2019)
        • 3.4.2 North America Zonisamide Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Zonisamide Production
        • 3.5.1 Europe Zonisamide Production Growth Rate (2014-2019)
        • 3.5.2 Europe Zonisamide Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Zonisamide Production (2014-2019)
        • 3.6.1 China Zonisamide Production Growth Rate (2014-2019)
        • 3.6.2 China Zonisamide Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Zonisamide Production (2014-2019)
        • 3.7.1 Japan Zonisamide Production Growth Rate (2014-2019)
        • 3.7.2 Japan Zonisamide Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Zonisamide Consumption by Regions

      • 4.1 Global Zonisamide Consumption by Regions
      • 4.2 North America Zonisamide Consumption (2014-2019)
      • 4.3 Europe Zonisamide Consumption (2014-2019)
      • 4.4 China Zonisamide Consumption (2014-2019)
      • 4.5 Japan Zonisamide Consumption (2014-2019)

      5 Global Zonisamide Production, Revenue, Price Trend by Type

      • 5.1 Global Zonisamide Production Market Share by Type (2014-2019)
      • 5.2 Global Zonisamide Revenue Market Share by Type (2014-2019)
      • 5.3 Global Zonisamide Price by Type (2014-2019)
      • 5.4 Global Zonisamide Production Growth by Type (2014-2019)

      6 Global Zonisamide Market Analysis by Applications

      • 6.1 Global Zonisamide Consumption Market Share by Application (2014-2019)
      • 6.2 Global Zonisamide Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Zonisamide Business

      • 7.1 Concordia
        • 7.1.1 Concordia Zonisamide Production Sites and Area Served
        • 7.1.2 Zonisamide Product Introduction, Application and Specification
        • 7.1.3 Concordia Zonisamide Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Eisai
        • 7.2.1 Eisai Zonisamide Production Sites and Area Served
        • 7.2.2 Zonisamide Product Introduction, Application and Specification
        • 7.2.3 Eisai Zonisamide Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Zydus Pharmaceuticals
        • 7.3.1 Zydus Pharmaceuticals Zonisamide Production Sites and Area Served
        • 7.3.2 Zonisamide Product Introduction, Application and Specification
        • 7.3.3 Zydus Pharmaceuticals Zonisamide Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Sun Pharma
        • 7.4.1 Sun Pharma Zonisamide Production Sites and Area Served
        • 7.4.2 Zonisamide Product Introduction, Application and Specification
        • 7.4.3 Sun Pharma Zonisamide Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Wockhardt
        • 7.5.1 Wockhardt Zonisamide Production Sites and Area Served
        • 7.5.2 Zonisamide Product Introduction, Application and Specification
        • 7.5.3 Wockhardt Zonisamide Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Mylan
        • 7.6.1 Mylan Zonisamide Production Sites and Area Served
        • 7.6.2 Zonisamide Product Introduction, Application and Specification
        • 7.6.3 Mylan Zonisamide Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 APOTEX
        • 7.7.1 APOTEX Zonisamide Production Sites and Area Served
        • 7.7.2 Zonisamide Product Introduction, Application and Specification
        • 7.7.3 APOTEX Zonisamide Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Teva
        • 7.8.1 Teva Zonisamide Production Sites and Area Served
        • 7.8.2 Zonisamide Product Introduction, Application and Specification
        • 7.8.3 Teva Zonisamide Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Glenmark
        • 7.9.1 Glenmark Zonisamide Production Sites and Area Served
        • 7.9.2 Zonisamide Product Introduction, Application and Specification
        • 7.9.3 Glenmark Zonisamide Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Bluepharma
        • 7.10.1 Bluepharma Zonisamide Production Sites and Area Served
        • 7.10.2 Zonisamide Product Introduction, Application and Specification
        • 7.10.3 Bluepharma Zonisamide Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Invagen Pharmaceuticals
      • 7.12 Intas Pharmaceuticals

      8 Zonisamide Manufacturing Cost Analysis

      • 8.1 Zonisamide Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Zonisamide
      • 8.4 Zonisamide Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Zonisamide Distributors List
      • 9.3 Zonisamide Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Zonisamide Market Forecast

      • 11.1 Global Zonisamide Production, Revenue Forecast
        • 11.1.1 Global Zonisamide Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Zonisamide Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Zonisamide Price and Trend Forecast (2019-2025)
      • 11.2 Global Zonisamide Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Zonisamide Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Zonisamide Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Zonisamide Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Zonisamide Production, Revenue Forecast (2019-2025)
      • 11.3 Global Zonisamide Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Zonisamide Consumption Forecast (2019-2025)
        • 11.3.2 Europe Zonisamide Consumption Forecast (2019-2025)
        • 11.3.3 China Zonisamide Consumption Forecast (2019-2025)
        • 11.3.4 Japan Zonisamide Consumption Forecast (2019-2025)
      • 11.4 Global Zonisamide Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Zonisamide Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Zonisamide is a medication used to treat the symptoms of epilepsy and Parkinson's disease.

        The global Zonisamide market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Zonisamide volume and value at global level, regional level and company level. From a global perspective, this report represents overall Zonisamide market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Concordia
        Eisai
        Zydus Pharmaceuticals
        Sun Pharma
        Wockhardt
        Mylan
        APOTEX
        Teva
        Glenmark
        Bluepharma
        Invagen Pharmaceuticals
        Intas Pharmaceuticals

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        25mg
        50mg
        100mg

        Segment by Application
        Adult
        Pediatric
        Geriatric

        Buy now